ANIX
Price
$2.75
Change
-$0.04 (-1.43%)
Updated
Sep 23 closing price
Capitalization
96.99M
104 days until earnings call
Intraday BUY SELL Signals
PRME
Price
$3.13
Change
-$0.41 (-11.58%)
Updated
Sep 23 closing price
Capitalization
642.07M
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANIX vs PRME

ANIX vs PRME Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ANIX vs. PRME commentary
Sep 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and PRME is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ANIX vs PRME: Fundamental Ratings
ANIX
PRME
OUTLOOK RATING
1..100
6255
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
7651
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRME's Valuation (34) in the null industry is in the same range as ANIX (59) in the Computer Peripherals industry. This means that PRME’s stock grew similarly to ANIX’s over the last 12 months.

PRME's Profit vs Risk Rating (100) in the null industry is in the same range as ANIX (100) in the Computer Peripherals industry. This means that PRME’s stock grew similarly to ANIX’s over the last 12 months.

PRME's SMR Rating (95) in the null industry is in the same range as ANIX (98) in the Computer Peripherals industry. This means that PRME’s stock grew similarly to ANIX’s over the last 12 months.

PRME's Price Growth Rating (51) in the null industry is in the same range as ANIX (76) in the Computer Peripherals industry. This means that PRME’s stock grew similarly to ANIX’s over the last 12 months.

PRME's P/E Growth Rating (100) in the null industry is in the same range as ANIX (100) in the Computer Peripherals industry. This means that PRME’s stock grew similarly to ANIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIXPRME
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
82%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 1 day ago
86%
COMPARISON
Comparison
Sep 24, 2026
Stock price -- (ANIX: $2.75 vs. PRME: $3.13)
Brand notoriety: ANIX and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 121% vs. PRME: 118%
Market capitalization -- ANIX: $96.99M vs. PRME: $642.07M
ANIX [@Biotechnology] is valued at $96.99M. PRME’s [@Biotechnology] market capitalization is $642.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.53B. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green while PRME’s FA Score has 0 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, PRME is a better buy in the long-term than ANIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 5 TA indicator(s) are bullish while PRME’s TA Score has 4 bullish TA indicator(s).

  • ANIX’s TA Score: 5 bullish, 6 bearish.
  • PRME’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ANIX and PRME are a bad buy in the short-term.

Price Growth

ANIX (@Biotechnology) experienced а +5.77% price change this week, while PRME (@Biotechnology) price change was +4.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.56%. For the same industry, the average monthly price growth was -9.72%, and the average quarterly price growth was +7.23%.

Reported Earning Dates

ANIX is expected to report earnings on Jan 06, 2027.

PRME is expected to report earnings on Oct 30, 2026.

Industries' Descriptions

@Biotechnology (-0.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ANIX
Daily Signal:
Gain/Loss:
PRME
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDHL0.54N/A
+0.39%
Redhill Biopharma Ltd
BALL58.82-1.15
-1.92%
Ball Corp
EVO1.54-0.04
-2.53%
Evotec SE
NAMS22.68-0.64
-2.74%
NewAmsterdam Pharma Company NV
ZSTK3.92-0.13
-3.21%
ZeroStack Corp.

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with MGX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then MGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
+3.33%
MGX - ANIX
41%
Loosely correlated
+1.79%
TNYA - ANIX
39%
Loosely correlated
+1.25%
RCKT - ANIX
38%
Loosely correlated
+2.45%
PRME - ANIX
38%
Loosely correlated
+10.97%
LXEO - ANIX
37%
Loosely correlated
-0.25%
More